Graves' disease

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses
Clinical Trials Arena
Mon, 09/9/24 - 11:16 am
Immunovant
Graves' disease
IMVT-1402
monoclonal antibodies
clinical trials
Immunovant stakes claim for FcRn niche, posting midphase Graves’ data and plotting next steps
Fierce Biotech
Thu, 12/21/23 - 09:46 am
Immunovant
anti-FcRn
clinical trials
Graves' disease
Roivant
Horizon teams up with Olympic champion to raise awareness around Graves' disease and thyroid eye disease
Fierce Pharma
Mon, 07/12/21 - 10:36 am
Horizon Therapeutics
Graves' disease
thyroid eye disease
Horizon looks for a new growth driver
EP Vantage
Mon, 10/28/19 - 10:33 am
Horizon
Graves' disease
teprotumumab